AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Vinci S.A.
Video analysis: VCISY
All videosNo video analysis for this stock yet. Request one from our team.
News: VCISY
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Largest comparative meta-analysis of its kind found da Vinci robotic-assisted surgery was associated with shorter hospital stays and a faster return to work compared with laparoscopic and open surgery Largest comparative meta-analysis of its kind found da Vinci robotic-assisted surgery was associated with shorter hospital stays and a faster return to work compared with laparoscopic and open surgery
Should Value Investors Buy Vinci (VCISY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Critical Contrast: Cadeler A/S (NYSE:CDLR) & Vinci (OTCMKTS:VCISY)
Vinci (OTCMKTS:VCISY - Get Free Report) and Cadeler A/S (NYSE: CDLR - Get Free Report) are both industrials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Risk and Volatility Vinci has a beta of 0.59,
Vinci Compass Investments Q2 Earnings Call Highlights
Vinci Compass Investments NASDAQ: VINP reported second-quarter 2026 fee-related earnings of BRL 88.7 million, or BRL 1.35 per share, as management fees increased and the firm benefited from acquisitions and organic fundraising. The alternative asset manager's fee-related earnings margin reached 32.5%, while adjusted distributable earnings were BRL 63.3 million, or BRL 0.96 per share.
Vinci SA (OTCMKTS:VCISY) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Vinci SA (OTCMKTS:VCISY - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. Separately, Citigroup cut shares of
Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?
Intuitive Surgical's da Vinci 5 is gaining rapid adoption, fueling hospital upgrades as software enhancements build a potential multi-year capital cycle.
Vinci SA (VCISY) Q2 2026 Earnings Call Transcript
Vinci SA (VCISY) Q2 2026 Earnings Call Transcript
Vinci (VCISY) Expected to Announce Earnings on Wednesday
Vinci (OTCMKTS:VCISY - Get Free Report) will likely be releasing its resultson Wednesday, July 29th. Analysts expect the company to post earnings of $1.01 per share and revenue of $40.0555 billion for the quarter. Vinci Stock Performance Shares of OTCMKTS VCISY opened at $33.44 on Monday. Vinci has a 1 year low of $32.72 and
